Coloplast A/S (0QBON) Financial Statements
0 Followers
Coloplast A/S Financial Overview
Coloplast A/S's market cap is currently kr311.62B. The company's EPS TTM is kr13.64; its P/E ratio is 38.33; and it has a dividend yield of 4.74%. Coloplast A/S is estimated to report earnings on February 5, 2027, and the estimated EPS forecast is kr17.28. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 28.94B | kr 27.87B | kr 27.03B | kr 24.50B | kr 22.58B |
| Gross Profit | kr 19.25B | kr 18.14B | kr 18.27B | kr 16.33B | kr 15.53B |
| Operating Income | kr 7.36B | kr 7.58B | kr 7.32B | kr 6.77B | kr 6.44B |
| EBITDA | kr 11.79B | kr 8.34B | kr 8.57B | kr 7.73B | kr 7.23B |
| Net Income | kr 3.07B | kr 3.64B | kr 5.05B | kr 4.78B | kr 4.71B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 511.00M | kr 947.00M | kr 788.00M | kr 911.00M | kr 633.00M |
| Total Assets | kr 46.27B | kr 48.37B | kr 48.07B | kr 48.16B | kr 34.96B |
| Total Debt | kr 21.52B | kr 22.64B | kr 22.63B | kr 19.57B | kr 18.71B |
| Net Debt | kr 21.01B | kr 21.69B | kr 21.84B | kr 18.66B | kr 18.29B |
| Total Liabilities | kr 31.98B | kr 32.24B | kr 30.13B | kr 30.86B | kr 26.66B |
| Stockholders' Equity | kr 14.29B | kr 16.12B | kr 17.94B | kr 17.30B | kr 8.29B |
| Cash Flow | |||||
| Free Cash Flow | kr 6.62B | kr 5.34B | kr 1.60B | kr 2.98B | kr 3.96B |
| Operating Cash Flow | kr 8.01B | kr 6.64B | kr 2.77B | kr 4.23B | kr 5.10B |
| Investing Cash Flow | kr -1.73B | kr -1.25B | kr -1.34B | kr -8.96B | kr -11.76B |
| Financing Cash Flow | kr -6.75B | kr -5.19B | kr -1.52B | kr 5.26B | kr 6.59B |
Currency in DKK
